MedTrace Logo

Rehabilitating Visual Deficits Caused by Stroke

NCT04878861 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2021-05-10

No results posted yet for this study

Summary

This research aims to understand the efficacy of a visual training task to improve visual loss after stroke, also known as hemianopia. The investigators aim to understand whether training can improve vision and which areas or pathways in the brain are responsible for this improvement.

Conditions

  • Hemianopia
  • Hemianopsia
  • Quadrantanopia
  • Stroke Induced Vision Loss

Interventions

BEHAVIORAL

Training in the blind field

Participants will complete visual training at two locations in the blind field. These two locations of training will be determined at the baseline study visit (0 months) and will be located within the perimetry-defined blind field. The training programme involves discriminating the direction of motion in a small circle of moving dots. The computer software and a chin-rest will be loaned to each participant to complete training at home. Participants will perform 300 trials at each location in their blind field, 5 days a week for at least 24 weeks (40-60 minutes in total). The computer programme will automatically generate a record of participant performance after each home training session.

Sponsors & Collaborators

  • University of Rochester

    collaborator OTHER

  • University of Turin, Italy

    collaborator OTHER

  • University of Texas at Austin

    collaborator OTHER

  • University of Oxford

    lead OTHER

Principal Investigators

  • Holly Bridge, PhD · University of Oxford

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-12-13
Primary Completion
2024-10-16
Completion
2024-10-16

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04878861 on ClinicalTrials.gov